The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature reviews. Drug discovery 2019-01, Vol.18 (1), p.82-84
Hauptverfasser:	Krystal, Andrew D., Pizzagalli, Diego A., Mathew, Sanjay J., Sanacora, Gerard, Keefe, Richard, Song, Allen, Calabrese, Joseph, Goddard, Andrew, Goodman, Wayne, Lisanby, Sarah H., Smoski, Moria, Weiner, Richard, Iosifescu, Dan, Nurnberger, John, Szabo, Steven, Murrough, James, Shekhar, Anantha, Potter, William
Format:	Artikel
Sprache:	eng
Schlagworte:	631/154/436 631/378/1689 692/308/153 Analysis Anhedonia - drug effects Anxiety Biomarkers Biomedicine Biotechnology Brain research Cancer Research Care and treatment Central nervous system Central nervous system agents Central nervous system diseases Clinical trials Clinical Trials as Topic correspondence Dosage and administration Drug development Drug Development - methods Drug discovery Drug dosages Drug therapy Drugs Humans Hypotheses Magnetic resonance imaging Medical schools Medicinal Chemistry Molecular Medicine Narcotic Antagonists - therapeutic use National Institute of Mental Health (U.S.) Neurobiology Pharmacology/Toxicology Psychotropic drugs United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!